AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30502778 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention including home visits by community health workers, physician education, and text messaging
Number of subjects: 1432
Study 30502778 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1432
Study 30502778 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent intervention
Number of subjects: 1432
Study 29071924 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-reinforcing needling (HRN)
Number of subjects: 60
Study 29071924 — intervention group
Group type: COMPARATOR
Intervention: Control group (uniform reinforcing-reducing method)
Number of subjects: 60
Study 24964814 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 200 mg
Number of subjects: 23
Study 24964814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 22688551 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg twice daily)
Number of subjects: 90
Study 22688551 — intervention group
Group type: COMPARATOR
Intervention: Sitagliptin (100 mg once daily)
Number of subjects: 90
Study 20346182 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 IU/min vasopressin infusion
Number of subjects: 50
Study 20346182 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 50
Study 18714440 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 1730
Study 18714440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1730
Study 20214761 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (Camoquin plus) dosed at 300 and 600 mg of amodiaquine per tablet
Number of subjects: 322
Study 20214761 — intervention group
Group type: COMPARATOR
Intervention: Artemether-lumefantrine (Coartem)
Number of subjects: 322
Study 15585538 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (10 sessions over five months)
Number of subjects: 71
Study 15585538 — intervention group
Group type: COMPARATOR
Intervention: Waiting list for therapy
Number of subjects: 71
Study 12391340 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-flow ventriculoperitoneal shunt treatment
Number of subjects: 29
Study 12391340 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 29
Study 10518856 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental floss containing 0.25 mg tetrasodium pyrophosphate per cm
Number of subjects: 0
Study 10518856 — intervention group
Group type: COMPARATOR
Intervention: Placebo floss
Number of subjects: 0
Study 8077370 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous estradiol administration (100 micrograms)
Number of subjects: 20
Study 8077370 — intervention group
Group type: COMPARATOR
Intervention: Placebo session
Number of subjects: 20
Study 2644465 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (2 mg)
Number of subjects: 315
Study 2644465 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 315
Study 1228009 — intervention group
Group type: EXPERIMENTAL
Intervention: Betamethasone 17-valerate in a cream base containing DMSO
Number of subjects: 15
Study 11327066 — intervention group
Group type: EXPERIMENTAL
Intervention: One-stage full-mouth (OSFM) disinfection treatment
Number of subjects: 31
Study 11327066 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (control group)
Number of subjects: 31
Study 31551385 — intervention group
Group type: EXPERIMENTAL
Intervention: SToP activities (seeing, treating, and preventing skin infections)
Number of subjects: 0
Study 29053861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 3783
Study 29053861 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 3783
Study 26576663 — intervention group
Group type: EXPERIMENTAL
Intervention: MPFF 1000 mg once daily
Number of subjects: 174
Study 26576663 — intervention group
Group type: COMPARATOR
Intervention: MPFF 500 mg twice daily
Number of subjects: 174
Study 27129012 — intervention group
Group type: EXPERIMENTAL
Intervention: Olokizumab administered intravenously (iv) or subcutaneously (sc)
Number of subjects: 67
Study 27129012 — intervention group
Group type: EXPERIMENTAL
Intervention: Olokizumab
Number of subjects: 67
Study 22744665 — intervention group
Group type: EXPERIMENTAL
Intervention: Fipamezole 90 mg TID
Number of subjects: 179
Study 22744665 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 179
Study 19639377 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified black tea theaflavins (TFs) providing 77.5 mg
Number of subjects: 102
Study 19639377 — intervention group
Group type: EXPERIMENTAL
Intervention: Purified black tea theaflavins/catechins (TFs/catechins) providing 75.0 mg TFs plus 150.0 mg catechins and 195.0 mg of other polyphenols
Number of subjects: 102
Study 19639377 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 102
Study 17923296 — intervention group
Group type: EXPERIMENTAL
Intervention: Home therapy exercises after carpal tunnel release
Number of subjects: 150
Study 17923296 — intervention group
Group type: COMPARATOR
Intervention: Home therapy exercises plus therapist-directed program for 2 weeks
Number of subjects: 150
Study 15811165 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine (30 mg/day)
Number of subjects: 36
Study 15811165 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 36
Study 12196367 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational booklet
Number of subjects: 83
Study 12196367 — intervention group
Group type: COMPARATOR
Intervention: Usual information treatment options
Number of subjects: 83
Study 10622275 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg MDMA
Number of subjects: 4
Study 10622275 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg MDMA
Number of subjects: 4
Study 10622275 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (0.8 mg/kg)
Number of subjects: 4
Study 10622275 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA and alcohol
Number of subjects: 4
Study 10622275 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study 7860949 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg sodium PHT plus 1 mg folic acid per day
Number of subjects: 6
Study 7860949 — intervention group
Group type: COMPARATOR
Intervention: 300 mg sodium PHT per day
Number of subjects: 6
Study 1949301 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator (tPA) (100 mg over 3 hours)
Number of subjects: 20981
Study 1949301 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) (1.5 MU over one hour)
Number of subjects: 20981
Study 1949301 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin (12,500 U twice daily)
Number of subjects: 20981
Study 1949301 — intervention group
Group type: COMPARATOR
Intervention: No heparin
Number of subjects: 20981
Study 1949301 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator (tPA)
Number of subjects: 20981
Study 1949301 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 20981
Study 1949301 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin
Number of subjects: 20981
Study 7031858 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalidixic acid
Number of subjects: 43
Study 7031858 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 31498139 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-Assisted Gait Training (RAGT)
Number of subjects: 26
Study 31498139 — intervention group
Group type: COMPARATOR
Intervention: Conventional Gait Training (CG)
Number of subjects: 26
Study 29263366 — intervention group
Group type: EXPERIMENTAL
Intervention: Drisapersen (an antisense oligonucleotide targeting exon 51) in an open label study with 12 patients
Number of subjects: 66
Study 29263366 — intervention group
Group type: COMPARATOR
Intervention: Drisapersen in a phase 3 randomized, double blind, placebo controlled study involving 186 patients
Number of subjects: 66
Study 29263366 — intervention group
Group type: EXPERIMENTAL
Intervention: Drisapersen in an open label extension study after the phase 3 study
Number of subjects: 66
Study 25660483 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-decision prompt (PODP) intervention; delivered orally at the beginning and middle of presentations.
Number of subjects: 12
Study 25660483 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PODP intervention).
Number of subjects: 12
Study 24095896 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise (EX) - cycling for 1 hour at 75% V̇O2peak
Number of subjects: 9
Study 24095896 — intervention group
Group type: COMPARATOR
Intervention: Rest (REST) - control condition
Number of subjects: 9
Study 22605362 — intervention group
Group type: EXPERIMENTAL
Intervention: High-empathy group
Number of subjects: 71
Study 22605362 — intervention group
Group type: COMPARATOR
Intervention: Low-empathy group
Number of subjects: 71
Study 19183126 — intervention group
Group type: EXPERIMENTAL
Intervention: Systems Training for Emotional Predictability and Problem Solving (STEPPS)
Number of subjects: 0
Study 17475736 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy plus pharmacotherapy
Number of subjects: 124
Study 17475736 — intervention group
Group type: COMPARATOR
Intervention: Clinical management (medication plus intensive clinical management)
Number of subjects: 124
Study 17475736 — intervention group
Group type: COMPARATOR
Intervention: Clinical management
Number of subjects: 124
Study 15241750 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week hip-exercise intervention (strength and postural stability exercises)
Number of subjects: 34
Study 15241750 — intervention group
Group type: COMPARATOR
Intervention: Basic isometric and active range of motion exercises (control group)
Number of subjects: 34
Study 12541094 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol
Number of subjects: 41
Study 12541094 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 41
Study 9579760 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma Self Management Training (4 training sessions)
Number of subjects: 303
Study 9579760 — intervention group
Group type: COMPARATOR
Intervention: Regular care (Control group)
Number of subjects: 303
Study 7645553 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetanus toxoid vaccination in chronic renal failure patients
Number of subjects: 83
Study 7645553 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetanus toxoid vaccination in dialysis patients
Number of subjects: 83
Study 7645553 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetanus toxoid vaccination in transplant patients
Number of subjects: 83
Study 7645553 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched patients with mild essential hypertension and normal kidney function)
Number of subjects: 83
Study 7645553 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of antibody concentrations post-vaccination
Number of subjects: 83
Study 2670027 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium alginate dressing
Number of subjects: 107
Study 2670027 — intervention group
Group type: COMPARATOR
Intervention: Paraffin gauze dressing
Number of subjects: 107
Study 334604 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoprofen (Orudis) 100 mg suppository nightly for ten days
Number of subjects: 60
Study 334604 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin suppository nightly for ten days
Number of subjects: 60
Study 334604 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient's and doctor's assessment
Number of subjects: 60
Study 334604 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory examinations
Number of subjects: 60
Study 31418996 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback intervention (details not specified)
Number of subjects: 82
Study 29738168 — intervention group
Group type: EXPERIMENTAL
Intervention: Huobi Powder (12-hour application to the umbilicus, qd for 28 days)
Number of subjects: 72
Study 29738168 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 72
Study 25455610 — intervention group
Group type: EXPERIMENTAL
Intervention: PDL + rapamycin
Number of subjects: 23
Study 25455610 — intervention group
Group type: COMPARATOR
Intervention: PDL + placebo
Number of subjects: 23
Study 25455610 — intervention group
Group type: COMPARATOR
Intervention: rapamycin
Number of subjects: 23
Study 25455610 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 23
Study 23085040 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional Family Therapy (MDFT)
Number of subjects: 450
Study 23085040 — intervention group
Group type: COMPARATOR
Intervention: Individual Psychotherapy (IP)
Number of subjects: 450
Study 21362108 — intervention group
Group type: EXPERIMENTAL
Intervention: nabiximols (Sativex) as add-on therapy
Number of subjects: 572
Study 19258540 — intervention group
Group type: EXPERIMENTAL
Intervention: DFMO/sulindac
Number of subjects: 375
Study 19258540 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study 18164919 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol ER 300 mg
Number of subjects: 317
Study 18164919 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol ER 100 mg, 200 mg, and 300 mg
Number of subjects: 317
Study 18164919 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol ER 200 mg and 300 mg
Number of subjects: 317
Study 18164919 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol ER 200 mg
Number of subjects: 317
Study 18164919 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol ER
Number of subjects: 317
Study 18164919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 317
Study 15181043 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 nM Ang II
Number of subjects: 16
Study 15181043 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 microM Ang II
Number of subjects: 16
Study 15181043 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 microM Ang II + 48 microM hydralazine
Number of subjects: 16
Study 15181043 — intervention group
Group type: COMPARATOR
Intervention: Ringer solution (control)
Number of subjects: 16
Study 11773991 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril 3 mg once a day
Number of subjects: 40
Study 11773991 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril 6 mg once a day
Number of subjects: 40
Study 11773991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11773991 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirapril (both dosages combined)
Number of subjects: 40
Study 10372580 — intervention group
Group type: EXPERIMENTAL
Intervention: Binary-gamble question for health states (intermittent claudication and major amputation)
Number of subjects: 1003
Study 10372580 — intervention group
Group type: EXPERIMENTAL
Intervention: Disease-specific vignettes
Number of subjects: 1003
Study 10372580 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic vignettes
Number of subjects: 1003
Study 8556031 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 micrograms of ethinyl estradiol (EE) plus 250 micrograms of norgestimate
Number of subjects: 40
Study 8556031 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms of ethinyl estradiol (EE) plus 75 micrograms of gestodene
Number of subjects: 40
Study 2371369 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg/day haloperidol
Number of subjects: 47
Study 2371369 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg/day haloperidol
Number of subjects: 47
Study 2371369 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg/day haloperidol
Number of subjects: 47
Study 2371369 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood levels of plasma and RBC haloperidol
Number of subjects: 47
Study 101317 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous pollen extract (SDV), 18 doses
Number of subjects: 153
Study 101317 — intervention group
Group type: COMPARATOR
Intervention: Glutaraldehyde-treated pollen-tyrosine adsorbate (Pollinex), 3 doses
Number of subjects: 153
Study 31682941 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital DPP (small group support, personalized health coaching, digital tracking tools, weekly behavior change curriculum)
Number of subjects: 241
Study 31682941 — intervention group
Group type: COMPARATOR
Intervention: Small group in-person class
Number of subjects: 241
Study 30588860 — intervention group
Group type: EXPERIMENTAL
Intervention: α‐HICA
Number of subjects: 40
Study 30588860 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB‐FA
Number of subjects: 40
Study 30588860 — intervention group
Group type: EXPERIMENTAL
Intervention: HMB‐Ca
Number of subjects: 40
Study 30588860 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 40
Study 27570184 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Attention Control Training Program (Food-ACTP)
Number of subjects: 49
Study 27570184 — intervention group
Group type: COMPARATOR
Intervention: No-intervention (control)
Number of subjects: 49
Study 27570184 — intervention group
Group type: COMPARATOR
Intervention: Sham-intervention
Number of subjects: 49
Study 24778436 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Triple P (8 sessions) + Treatment as Usual (TAU)
Number of subjects: 27
Study 24778436 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU) only
Number of subjects: 27
Study 23768119 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored Interactive Health Communication Application (IHCA)
Number of subjects: 414
Study 23768119 — intervention group
Group type: COMPARATOR
Intervention: Standard website (control)
Number of subjects: 414
Study 23768119 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored IHCA
Number of subjects: 414
Study 21888642 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Salt (50% sodium chloride, 25% potassium chloride, 25% magnesium ammonium potassium chloride)
Number of subjects: 45
Study 21888642 — intervention group
Group type: COMPARATOR
Intervention: Regular salt (NaCl)
Number of subjects: 45
Study 20027086 — intervention group
Group type: EXPERIMENTAL
Intervention: All 5-mm ports approach
Number of subjects: 40
Study 20027086 — intervention group
Group type: COMPARATOR
Intervention: Conventional approach
Number of subjects: 40
Study 17908750 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk ingestion during NICU hospitalization
Number of subjects: 773
Study 17908750 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in breast milk ingestion (10 mL/kg per day)
Number of subjects: 773
Study 17908750 — intervention group
Group type: COMPARATOR
Intervention: No breast milk ingestion
Number of subjects: 773
Study 14661081 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxadent (DD)
Number of subjects: 8
Study 14661081 — intervention group
Group type: COMPARATOR
Intervention: Tetric Ceram/Syntac Single-Component (TC/SS)
Number of subjects: 8
Study 16225606 — intervention group
Group type: EXPERIMENTAL
Intervention: Excimer laser treatment (twice weekly)
Number of subjects: 22
Study 16225606 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Dye Laser (PDL) treatment (every 4 weeks, pretreated with salicylic acid)
Number of subjects: 22
Study 16225606 — intervention group
Group type: COMPARATOR
Intervention: Salicylic acid alone (control)
Number of subjects: 22
Study 16225606 — intervention group
Group type: COMPARATOR
Intervention: Untreated control plaques
Number of subjects: 22
Study 11858005 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluative sciences
Number of subjects: 0
Study 11858005 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessing efficacy, (cost‐)effectiveness, and cost‐utility of clinical technologies
Number of subjects: 0
Study 9059669 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical steroid treatment for 4 weeks
Number of subjects: 0
Study 9059669 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 8337620 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 461
Study 8337620 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 461
Study 3567121 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin titration to achieve a preset frequency of 6-7 uterine contractions every 15 min
Number of subjects: 114
Study 3567121 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin titration to achieve uterine activity equivalent to the 75th centile for spontaneous labour
Number of subjects: 114
Study 2523581 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hour back school psychoeducational session (LBS)
Number of subjects: 222
Study 2523581 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-year 'compliance package' program (CP)
Number of subjects: 222
Study 2523581 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 222
Study 31237250 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional Bias Modification Training (ABMT)
Number of subjects: 33
Study 31237250 — intervention group
Group type: COMPARATOR
Intervention: Sham ABMT (Control)
Number of subjects: 33
Study 31237250 — intervention group
Group type: EXPERIMENTAL
Intervention: ABMT
Number of subjects: 33
Study 27112919 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative writing intervention
Number of subjects: 70
Study 27112919 — intervention group
Group type: COMPARATOR
Intervention: Control group (no narrative writing)
Number of subjects: 70
Study 27112919 — intervention group
Group type: COMPARATOR
Intervention: Comparison between intervention and control groups
Number of subjects: 70
Study 24966113 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD-delivered exercise program (FlexToBa™)
Number of subjects: 307
Study 24966113 — intervention group
Group type: COMPARATOR
Intervention: Healthy aging DVD control group
Number of subjects: 307
Study 23585499 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory intervention to improve psychosocial work environment for 6 months
Number of subjects: 434
Study 23585499 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 434
Study 21406450 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 150
Study 21406450 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous blood injection (ABI)
Number of subjects: 150